
Keywords: پارامترهای فارماکوکینتیک; Antiplatelet; Preclinical studies; Structure-activity relationship (SAR) studies; Pharmacokinetic parameters; Safety profile; AA; arachidonic acid; ADP; adenosine diphosphate; ATP; adenosine triphosphate; CNS; central nervous system; COX-1; cyclooxygenase